These findings suggest that SGMS2 variants modulate circadian rhythm and gap junction assembly, adversely affecting bone health and homeostasis, and may affect neuron-supporting cells in SGMS2-related osteoporosis. The gene discussed is SGMS2; the disease is osteoporosis.